{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:22:05Z","timestamp":1790475725783,"version":"4.1.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Transregio 60"],"award-info":[{"award-number":["Transregio 60"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00614","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T04:29:57Z","timestamp":1524457797000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Induction of Type I Interferons by Therapeutic Nanoparticle-Based Vaccination Is Indispensable to Reinforce Cytotoxic CD8+ T Cell Responses During Chronic Retroviral Infection"],"prefix":"10.3389","volume":"9","author":[{"given":"Torben","family":"Knuschke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Rotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wibke","family":"Bayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Kollenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Dickow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Dittmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl S.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Epple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Buer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid M.","family":"Westendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1073\/pnas.1015148108","article-title":"Transient depletion of regulatory T cells in transgenic mice reactivates virus-specific CD8+ T cells and reduces chronic retroviral set points","volume":"108","author":"Dietze","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/COH.0000000000000286","article-title":"Kill: boosting HIV-specific immune responses","volume":"11","author":"Trautmann","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"B4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00262-016-1834-5","article-title":"Designing therapeutic cancer vaccines by mimicking viral infections","volume":"66","author":"Sultan","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"B5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1126\/science.1255512","article-title":"Immunologic strategies for HIV-1 remission and eradication","volume":"345","author":"Barouch","year":"2014","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.coviro.2016.02.001","article-title":"Which therapeutic strategy will achieve a cure for HIV-1?","volume":"18","author":"Cillo","year":"2016","journal-title":"Curr Opin Virol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1007\/s11051-012-0910-9","article-title":"Calcium phosphate nanoparticles as versatile carrier for small and large molecules across cell membranes","volume":"14","author":"Sokolova","year":"2012","journal-title":"J Nanopart Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5627","DOI":"10.1016\/j.biomaterials.2010.03.067","article-title":"The use of calcium phosphate nanoparticles encapsulating toll-like receptor ligands and the antigen hemagglutinin to induce dendritic cell maturation and T cell activation","volume":"31","author":"Sokolova","year":"2010","journal-title":"Biomaterials"},{"key":"B9","doi-asserted-by":"publisher","first-page":"6221","DOI":"10.4049\/jimmunol.1202654","article-title":"Immunization with biodegradable nanoparticles efficiently induces cellular immunity and protects against influenza virus infection","volume":"190","author":"Knuschke","year":"2013","journal-title":"J Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.nano.2014.06.014","article-title":"Prophylactic and therapeutic vaccination with a nanoparticle-based peptide vaccine induces efficient protective immunity during acute and chronic retroviral infection","volume":"10","author":"Knuschke","year":"2014","journal-title":"Nanomedicine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12977-016-0258-9","article-title":"Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection","volume":"13","author":"Knuschke","year":"2016","journal-title":"Retrovirology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/intimm\/dxh186","article-title":"Toll-like receptors in innate immunity","volume":"17","author":"Takeda","year":"2005","journal-title":"Int Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1002352","DOI":"10.1371\/journal.ppat.1002352","article-title":"Type 1 interferons and antiviral CD8 T-cell responses","volume":"8","author":"Welsh","year":"2012","journal-title":"PLoS Pathog"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"Muller","year":"1994","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1182\/blood.V99.9.3263","article-title":"Type I interferons produced by dendritic cells promote their phenotypic and functional activation","volume":"99","author":"Montoya","year":"2002","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.4049\/jimmunol.174.8.4465","article-title":"Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation","volume":"174","author":"Curtsinger","year":"2005","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1084\/jem.20050821","article-title":"Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection","volume":"202","author":"Kolumam","year":"2005","journal-title":"J Exp Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1006\/clim.2001.5111","article-title":"Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors","volume":"101","author":"Feldman","year":"2001","journal-title":"Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1128\/JVI.80.7.3438-3444.2006","article-title":"Effects of type I interferons on Friend retrovirus infection","volume":"80","author":"Gerlach","year":"2006","journal-title":"J Virol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1038\/cti.2014.1","article-title":"Interferon-alpha, immune activation and immune dysfunction in treated HIV infection","volume":"3","author":"Cha","year":"2014","journal-title":"Clin Transl Immunology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.1128\/JVI.00451-16","article-title":"Interferon alpha subtype-specific suppression of HIV-1 infection in vivo","volume":"90","author":"Lavender","year":"2016","journal-title":"J Virol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e1005254","DOI":"10.1371\/journal.ppat.1005254","article-title":"Interferon-alpha subtypes in an ex vivo model of acute HIV-1 infection: expression, potency and effector mechanisms","volume":"11","author":"Harper","year":"2015","journal-title":"PLoS Pathog"},{"key":"B23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/nature13554","article-title":"Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression","volume":"511","author":"Sandler","year":"2014","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.1235214","article-title":"Persistent LCMV infection is controlled by blockade of type I interferon signaling","volume":"340","author":"Teijaro","year":"2013","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1126\/science.1235208","article-title":"Blockade of chronic type I interferon signaling to control persistent LCMV infection","volume":"340","author":"Wilson","year":"2013","journal-title":"Science"},{"key":"B26","doi-asserted-by":"publisher","first-page":"10619","DOI":"10.1128\/JVI.79.16.10619-10626.2005","article-title":"CD8+ T-cell dysfunction due to cytolytic granule deficiency in persistent Friend retrovirus infection","volume":"79","author":"Zelinskyy","year":"2005","journal-title":"J Virol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"6179","DOI":"10.4049\/jimmunol.1000858","article-title":"Polyinosinic-polycytidylic acid treatment of Friend retrovirus-infected mice improves functional properties of virus-specific T cells and prevents virus-induced disease","volume":"185","author":"Gibbert","year":"2010","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"crossref","first-page":"11284","DOI":"10.1073\/pnas.92.24.11284","article-title":"A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses","volume":"92","author":"Hwang","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1084\/jem.20061852","article-title":"Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease","volume":"204","author":"Lahl","year":"2007","journal-title":"J Exp Med"},{"key":"B30","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/JVI.52.2.695-698.1984","article-title":"A Mus dunni cell line that lacks sequences closely related to endogenous murine leukemia viruses and can be infected by ectropic, amphotropic, xenotropic, and mink cell focus-forming viruses","volume":"52","author":"Lander","year":"1984","journal-title":"J Virol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1016\/j.actbio.2011.07.010","article-title":"Quantitative determination of the composition of multi-shell calcium phosphate-oligonucleotide nanoparticles and their application for the activation of dendritic cells","volume":"7","author":"Sokolova","year":"2011","journal-title":"Acta Biomater"},{"key":"B32","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.1128\/JVI.70.11.7773-7782.1996","article-title":"Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors","volume":"70","author":"Chen","year":"1996","journal-title":"J Virol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1182\/blood-2007-05-092189","article-title":"Friend retrovirus infection of myeloid dendritic cells impairs maturation, prolongs contact to naive T cells, and favors expansion of regulatory T cells","volume":"110","author":"Balkow","year":"2007","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/343762a0","article-title":"Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor","volume":"343","author":"Li","year":"1990","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1084\/jem.140.6.1457","article-title":"Host genetic control of recovery from Friend leukemia virus-induced splenomegaly: mapping of a gene within the major histocompatability complex","volume":"140","author":"Chesebro","year":"1974","journal-title":"J Exp Med"},{"key":"B36","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.1128\/JVI.72.8.6554-6558.1998","article-title":"Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms","volume":"72","author":"Dittmer","year":"1998","journal-title":"J Virol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0166-0934(91)90105-9","article-title":"Production of monoclonal antibodies reactive with a denatured form of the Friend murine leukemia virus gp70 envelope protein: use in a focal infectivity assay, immunohistochemical studies, electron microscopy and western blotting","volume":"34","author":"Robertson","year":"1991","journal-title":"J Virol Methods"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e1002868","DOI":"10.1371\/journal.ppat.1002868","article-title":"Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection","volume":"8","author":"Gibbert","year":"2012","journal-title":"PLoS Pathog"},{"key":"B39","doi-asserted-by":"publisher","first-page":"14040","DOI":"10.1128\/JVI.02360-14","article-title":"Type I interferon signaling enhances CD8+ T cell effector function and differentiation during murine gammaherpesvirus 68 infection","volume":"88","author":"Jennings","year":"2014","journal-title":"J Virol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e1003798","DOI":"10.1371\/journal.ppat.1003798","article-title":"Combining regulatory T cell depletion and inhibitory receptor blockade improves reactivation of exhausted virus-specific CD8+ T cells and efficiently reduces chronic retroviral loads","volume":"9","author":"Dietze","year":"2013","journal-title":"PLoS Pathog"},{"key":"B41","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.chom.2012.05.003","article-title":"Timing and magnitude of type I interferon responses by distinct sensors impact CD8 T cell exhaustion and chronic viral infection","volume":"11","author":"Wang","year":"2012","journal-title":"Cell Host Microbe"},{"key":"B42","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1172\/JCI89488","article-title":"Targeting type I interferon-mediated activation restores immune function in chronic HIV infection","volume":"127","author":"Zhen","year":"2017","journal-title":"J Clin Invest"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1086\/652420","article-title":"Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial","volume":"201","author":"Asmuth","year":"2010","journal-title":"J Infect Dis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/infdis\/jis663","article-title":"Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration","volume":"207","author":"Azzoni","year":"2013","journal-title":"J Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1093\/infdis\/jis211","article-title":"Host gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with peginterferon Alfa-2a","volume":"205","author":"Hubbard","year":"2012","journal-title":"J Infect Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1073\/pnas.1111573109","article-title":"Role of retroviral restriction factors in the interferon-alpha-mediated suppression of HIV-1 in vivo","volume":"109","author":"Pillai","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B48","doi-asserted-by":"publisher","first-page":"5969","DOI":"10.4049\/jimmunol.0900526","article-title":"APC activation by IFN-alpha decreases regulatory T cell and enhances Th cell functions","volume":"184","author":"Pace","year":"2010","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00614\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T04:28:10Z","timestamp":1604204890000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00614\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,23]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2018.00614"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00614","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,23]]},"article-number":"614"}}